ANIP vs. INVA
Compare and contrast key facts about ANI Pharmaceuticals, Inc. (ANIP) and Innoviva, Inc. (INVA).
Performance
ANIP vs. INVA - Performance Comparison
Loading graphics...
ANIP vs. INVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ANIP ANI Pharmaceuticals, Inc. | -2.58% | 42.80% | 0.25% | 37.06% | -12.70% | 58.68% | -52.91% | 36.98% | -30.15% | 6.32% |
INVA Innoviva, Inc. | 16.56% | 15.22% | 8.17% | 21.06% | -23.19% | 39.23% | -12.50% | -18.85% | 22.97% | 32.62% |
Fundamentals
ANIP:
$1.63B
INVA:
$1.99B
ANIP:
$3.75
INVA:
$3.19
ANIP:
20.49
INVA:
7.29
ANIP:
0.14
INVA:
0.03
ANIP:
1.82
INVA:
4.81
ANIP:
3.02
INVA:
1.69
ANIP:
$883.37M
INVA:
$411.33M
ANIP:
$610.19M
INVA:
$307.67M
ANIP:
$225.70M
INVA:
$203.88M
Returns By Period
In the year-to-date period, ANIP achieves a -2.58% return, which is significantly lower than INVA's 16.56% return. Over the past 10 years, ANIP has outperformed INVA with an annualized return of 8.52%, while INVA has yielded a comparatively lower 6.15% annualized return.
ANIP
- 1D
- 4.33%
- 1M
- 4.06%
- YTD
- -2.58%
- 6M
- -16.05%
- 1Y
- 14.86%
- 3Y*
- 24.63%
- 5Y*
- 17.71%
- 10Y*
- 8.52%
INVA
- 1D
- 1.70%
- 1M
- 1.48%
- YTD
- 16.56%
- 6M
- 27.67%
- 1Y
- 28.52%
- 3Y*
- 27.47%
- 5Y*
- 14.27%
- 10Y*
- 6.15%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANIP vs. INVA — Risk / Return Rank
ANIP
INVA
ANIP vs. INVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ANI Pharmaceuticals, Inc. (ANIP) and Innoviva, Inc. (INVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ANIP | INVA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.40 | 1.02 | -0.61 |
Sortino ratioReturn per unit of downside risk | 0.93 | 1.86 | -0.93 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.21 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | 0.48 | 1.20 | -0.72 |
Martin ratioReturn relative to average drawdown | 0.97 | 2.86 | -1.89 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ANIP | INVA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.40 | 1.02 | -0.61 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.38 | 0.51 | -0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | 0.18 | -0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.05 | 0.06 | -0.11 |
Correlation
The correlation between ANIP and INVA is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ANIP vs. INVA - Dividend Comparison
Neither ANIP nor INVA has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANIP ANI Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
INVA Innoviva, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.12% |
Drawdowns
ANIP vs. INVA - Drawdown Comparison
The maximum ANIP drawdown since its inception was -98.81%, which is greater than INVA's maximum drawdown of -84.32%. Use the drawdown chart below to compare losses from any high point for ANIP and INVA.
Loading graphics...
Drawdown Indicators
| ANIP | INVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.81% | -84.32% | -14.49% |
Max Drawdown (1Y)Largest decline over 1 year | -28.66% | -23.53% | -5.13% |
Max Drawdown (5Y)Largest decline over 5 years | -59.38% | -47.01% | -12.37% |
Max Drawdown (10Y)Largest decline over 10 years | -72.96% | -59.57% | -13.39% |
Current DrawdownCurrent decline from peak | -82.91% | -27.14% | -55.77% |
Average DrawdownAverage peak-to-trough decline | -79.38% | -44.79% | -34.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.22% | 9.85% | +4.37% |
Volatility
ANIP vs. INVA - Volatility Comparison
ANI Pharmaceuticals, Inc. (ANIP) has a higher volatility of 9.44% compared to Innoviva, Inc. (INVA) at 6.54%. This indicates that ANIP's price experiences larger fluctuations and is considered to be riskier than INVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ANIP | INVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.44% | 6.54% | +2.90% |
Volatility (6M)Calculated over the trailing 6-month period | 22.59% | 22.06% | +0.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.90% | 28.15% | +8.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.10% | 27.88% | +19.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.62% | 34.05% | +14.57% |
Financials
ANIP vs. INVA - Financials Comparison
This section allows you to compare key financial metrics between ANI Pharmaceuticals, Inc. and Innoviva, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities